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Abstract
The value of knowledge assets generated by analytics processes using Data Science techniques tends to decay over
time, as a consequence of changes in the elements the process depends on: external data sources, libraries, and system
dependencies. For large-scale problems, refreshing those outcomes through greedy re-computation is both expensive
and inefficient, as some changes have limited impact. In this paper we address the problem of refreshing past process
outcomes selectively, that is, by trying to identify the subset of outcomes that will have been affected by a change,
and by only re-executing fragments of the original process. We propose a technical approach to address the selective
re-computation problem by combining multiple techniques, and present an extensive experimental study in Genomics,
namely variant calling and their clinical interpretation, to show its effectiveness. In this case study, we are able to
decrease the number of required re-computations on a cohort of individuals from 495 (blind) down to 71, and that we
can reduce runtime by at least 60% relative to the na¨ıve blind approach, and in some cases by 90%. Starting from this
experience, we then propose a blueprint for a generic re-computation meta-process that makes use of process history
metadata to make informed decisions about selective re-computations in reaction to a variety of changes in the data.
Keywords: re-computation, knowledge decay, big data analysis, genomics
1. Introduction
In Data Science applications, the insights generated
by resource-intensive data analytics processes may become
outdated as a consequence of changes in any of the ele-
ments involved in the process. Changes that cause insta-
blity include updates to reference data sources, to soft-
ware libraries, and changes to system dependencies, as
well as to the structure of the process itself. We address
the problem of efficiently restoring the currency of analyt-
ics outcomes in the presence of instability. This involves
a trade-off between the recurring cost of process update
and re-execution in the presence of changes on one side,
and the diminishing value of its obsolete outcomes, on the
other. Addressing the problem therefore requires knowl-
edge of the impact of a change, that is, to which extent
the change invalidates the analysis, as well as of the cost
involved in upgrading the process and running the analy-
sis again. Additionally, it may be possible to optimise the
re-analysis given prior outcomes and detailed knowledge
of, and control over, the analysis process.
1.1. Motivation: genomics data processing
In this paper we focus specifically on Genomics data
processing, as it is a relevant and paradigmatic case study
∗Corresponding author
Email addresses: Jacek.Cala@ncl.ac.uk (Jacek Ca la),
Paolo.Missier@ncl.ac.uk (Paolo Missier)
for experimenting with general re-computation strategies.
Next Generation Sequencing (NGS) pipelines are increas-
ingly employed to analyse individuals’ exomes (the coding
region of genes, representing about 1% of the genome),
and more recently whole genomes, to extract insight into
suspected genetic diseases, or to establish genetic risk fac-
tors associated with some of the most severe human dis-
eases [1, 2, 3]. NGS pipelines provide an ideal testbed to
study the re-computation problem, as they are relatively
unstable and are used to process large cohorts of individual
cases. They are also resource-intensive: exome files are of
the order of 10GB each, and a batch of 20–40 exomes is re-
quired for the results to be significant. Each 1TB+ input
batch requires over 100 CPU-hours to process. Specific
performance figures for our own pipeline implementation,
which runs on the Azure cloud, can be found in [4].
While the cost and execution time associated to a single
execution of these pipelines is decreasing over time [5, 4],
recent advances in preventive and personalised medicine [6]
translate into ambitious plans to deploy genomics analysis
at population scale. At the same time, although relatively
stable best practices are available to describe the general
structure of the analysis process,1 their implementations
make use of algorithms and tools that are subject to fre-
quent new releases, as well as of reference databases that
undergo regular revisions.
1https://software.broadinstitute.org/gatk/best-practices
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In this setting, failing to react to important changes
results in missed opportunities to improve on an individ-
ual’s genetic diagnosis. On the other hand, over-reacting
to each and every change is impractical and inefficient,
as in many cases the benefits of refresh may be marginal.
Using genomics data processing as a case study, we are
therefore motivated to explore techniques for selective and
incremental re-computation that optimise the use of the
available computing resources vis-a`-vis the expected bene-
fit of knowledge refresh on a population of prior outcomes.
1.2. Reacting to changes: a meta-process
To clarify the meaning of selectivity and incremental
re-computation in this context, consider: a collection C of
cases, e.g., a cohort of individuals’ genomes; an analysis
process P , e.g. an NGS pipeline; a collection of execu-
tions of P on each input xi ∈ C, which generate corre-
sponding outcomes yi with processing cost ci; and a set
D = {d1 . . . dm} of versioned dependencies, i.e., software
libraries or reference databases. When a new version D′j
of a dependency Dj ∈ D becomes available, we expect
the change Dj → D′j to have different impact on different
outputs yi computed at some earlier time: some of these
outputs will be unaffected, while others will be partially or
completely invalidated, as we will show in examples later.
We are going to define impact in terms of a change
on a specific output yi in terms of some type-specific diff
functions that compute the differences between two ver-
sions yi, y
′
i of an output. Assuming that expected impact
can be estimated, we define the scope of the change as the
subset of C ′ ⊆ C of inputs xi such that the change will
have non-zero impact on the corresponding output yi, and
the selectivity of the change as 1 − |C′||C| . Those xi ∈ C
that are within the scope of a change are candidates for
re-computation, and it may be possible to prioritise them
using knowledge of the cost ci of their earlier processing,
the quantified extent of impact, along with domain-specific
knowledge of their relative importance (for instance, more
severe genetic diagnoses). Such considerations, however,
are beyond the scope of this paper.
Instead, here we study techniques to (i) estimate the
scope of a change, without having to recompute each out-
put, and (ii) perform incremental re-computation: given
a white box specification of P , for instance as a script or
as a workflow, we want to efficiently identify the minimal
fragment of P that is affected by the change, in order to
optimise the re-computation of the xi that are within the
scope of the change. We define such techniques within the
framework of the ReComp meta-process. ReComp takes as
input a history of prior analysis and a change event, as in-
dicated above, and controls the incremental re-execution
of the underlying process P on selected inputs that are
within the scope of the change.
Not all scenarios involving C, P , and changes in P ’s
dependencies are equally suitable for optimisation using
ReComp, however. Specifically, ReComp is most effective
when changes have high selectivity (only few of the cases
are affected), when process P is a white box ; and when the
change affects only a few of P ’s components, providing
scope for incremental re-computation. In the next sec-
tion we select our target case study following these three
requirements, by analysing three scenarios involving dif-
ferent reference data and software tool changes within the
realm of Genomics. Firstly, however, we must briefly de-
scribe NGS pipelines.
1.3. Variant calling and interpretation
Fig. 1 depicts the anatomy of the NGS pipeline imple-
mentation available from our lab. It consists of two main
phases: (i) exome analysis and variant calling and anno-
tation [4], and (ii) variant interpretation [7]. The first
phase closely follows the guidelines issued by the Broad
Institute.2 It takes a batch of raw input exomes and, for
each of them, produces a corresponding list of variants, or
mutations, defined relative to the current reference human
genome (in the order of tens of thousands). Particularly
critical in this phase are the choices of reference genome,
currently at version h19, and the choice and version of
the variant caller. Currently we use FreeBayes [8], one of
several such algorithms [9]. At the end of this phase, each
variant will have been annotated using a variety of statisti-
cal predictors of the likelihood that the variant contributes
to a specific genetic disease.
Only a very small fraction of these variants are delete-
rious, however. The second phase, which we have called
Simple Variant Interpretation (SVI in the figure), aims to
identify those the few tens of variants that may be respon-
sible for an individual’s phenotype, i.e., the manifestation
of a suspected genetic disease. In addition to using the
predictors, SVI also makes use of databases that associate
phenotype descriptions with sets of genes that are known
to be broadly implicated in the phenotypes, such as OMIM
GeneMap,3. It also uses databases of known variants and
their deleteriousness such as NCBI ClinVar,4 HGMD,5 and
possibly others.6
In more detail, the SVI portion of the pipeline consists
of three main steps (Fig. 2): (1) mapping the user-provided
clinical terms that describe a patient’s phenotype to a set
of relevant genes (genes-in-scope), (2) selection of those
variants that are in scope, that is, the subset of the pa-
tient’s variants that are located on the genes-in-scope, and
(3) annotation and classification of the variants-in-scope
according to their expected pathogenicity. Classification
consists of a simple traffic-light system {red, green, and
amber} to denote pathogenic, benign and variants of un-
known or uncertain pathogenicity, respectively. In this
process, the class of a variant is determined simply by its
2https://software.broadinstitute.org/gatk/best-practices
3http://data.omim.org
4https://www.ncbi.nlm.nih.gov/clinvar
5http://www.hgmd.cf.ac.uk
6http://grenada.lumc.nl/LSDB_list/lsdbs
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Figure 1: The Next Generation Sequencing pipeline; highlighted is the variant classification step.
pathogenicity status as reported in ClinVar. Importantly,
if any of the patient variants is marked as red, the pheno-
type hypothesis is deemed to be confirmed, with more red
variants interpreted as stronger confirmation.
1.4. Candidate re-computation scenarios
We now present three real scenarios for changes to the
processing pipeline just described, as candidates for our in-
depth experimentation: (i) a step change in the reference
genome assembly, (ii) version upgrade to the variant caller,
and (iii) updates to one of the SVI reference databases,
ClinVar.
1.4.1. Step change in reference genome assembly
The reference genome is currently undergoing major
changes within the bioinformatics community. The history
of how the Genome Reference Consortium (GRC) man-
aged the progression of the human genome assembly since
2007 is summarised for instance in [10]. While this pro-
vides detailed insight for the interested reader, for our pur-
poses it suffices to note that the Global Alliance for Global
Health7 is working on a new reference genome, h38, that
is so drastically different from its predecessors, to require
a re-design of most tools and of the entire pipeline. There
are two main reasons why h38 will be disruptive. Firstly,
it will be graph-structured, taking into account multiple
possible transcriptions of the same gene (i.e., during pro-
tein synthesis), and secondly, it is the first coordinate-
changing assembly update since 2009 [11]. Such disrup-
tive step-changes are rare, however, as the current genome
assembly, h19, has been stable for a number of years and
is likely to remain in use for quite some time. From the
ReComp perspective, this change is likely to have very low
selectivity, i.e., every case in C (every genome ever pro-
cessed) will be affected, while not leaving much space for
fine-grained selection of sub-processed with the established
pipeline P , because most of its elements will be disrupted.
1.4.2. Variant caller version change
Complementary to updates in reference datasets, new
releases for one of the tools that make up the pipeline
also represent notable change events that may trigger re-
computation. The Freebayes caller we use in our pipeline,
for instance, has seen multiple releases between 12/2013
7http://genomicsandhealth.org/
(v0.9.10) and 04/2018 (v1.2.0, current at the time of writ-
ing). To assess the broad impact of these changes, we
have compared the output variant sets for 16 patients us-
ing three versions of the caller, namely v0.9.10, v1.0.2
(12/2015), and v1.1 (11/2016). The results, shown in
Fig. 3, are consistent with other, more extensive compar-
ative studies like [12]. In particular, we can see that over
50,000 of the variants that appear in the v0.9.x output are
no longer identified as such in v1.0.2, representing a sub-
stantial 10.3% false positive detection over the previous
version. Conversely, the minor version upgrades are much
more consistent with each other. This provides empiri-
cal evidence of instability of analysis outcomes especially
in the early releases of new critical algorithms as part of
established pipelines.
1.4.3. Updates to the SVI reference databases
Our third candidate change scenario involves ver-
sion changes in ClinVar, one of the reference databases
used in the SVI portion of the pipeline. We analysed
the variants for a cohort of 33 patients for three dis-
tinct phenotypes: Alzheimer’s disease, Frontotemporal
Dementia-Amyotrophic Lateral Sclerosis (FTD-ALS) and
the CADASIL syndrome. For each patient we ran SVI us-
ing consecutive monthly versions of ClinVar, from 07/2015
to 10/2016, for a total of 16 re-runs per patient, and
recorded whether the new version would have modified
a diagnosis that had been obtained using the previous
version. A change in diagnosis occurs when new variants
are added to the selection, others are removed, or existing
variants change their classification because their status in
ClinVar has changed.
Table 1 summarises the results. We recorded four types
of outcomes. Firstly, confirming the current diagnosis (),
which happens when additional variants are added to the
red class. Secondly, retracting the diagnosis, which may
happen (rarely) when all red variants are retracted, de-
noted v. Thirdly, changes in the amber class which do not
alter the diagnosis (), and finally, no change at all ( ).
These results, however limited in scope, suggest good
selectivity for this type of change. Indeed, the majority of
the changes reported here are ultimately of low interest to
clinicians, and so greedy re-computation would be highly
inefficient. This comes as little surprise because some hu-
man genetic diseases tend to be underpinned by a very
few rare variants [13], whilst those associated with com-
mon diseases (as above) are widely studied. Therefore, the
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Figure 2: The high-level architecture of the SVI process.
Table 1: Changes observed in the output of the SVI tool for a cohort of 33 patients following updates in the NCBI ClinVar reference database
between July 2015 and October 2016;  and v – significant (positive and negative) changes in the SVI output,  – insignificant change in
the output, ‘ ’ – no change at all.
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Figure 3: Variations in variants produced by different versions of the
FreeBayes caller
knowledge about them is quite stable, especially when con-
sidered on a monthly time scale. This also suggests that
rare diseases may provide a more compelling case for se-
lective re-computation, as knowledge about them is more
likely to evolve over time. Finally, we note that some up-
dates have a higher impact than others, for instance the
08/2016 release of ClnVar.
1.4.4. Choice of target experimental study
The characteristics of the changes just presented are
summarised in Table 2. As noted above, a reference
genome change results in low sensitivity and little chance
for optimisation of process re-run, limiting the effective-
ness of ReComp in this case. In contrast, both the variant
caller version change and the SVI reference data changes
are good candidates, providing potentially good selectiv-
ity. Compared to a change in software, however, changes
in reference data have the additional advantage that we
can apply techniques based on fine-grained differencing of
4
Table 2: Comparison between of changes and expected ReComp effectiveness
Change ReComp effectiveness
Scenario Type Rate Granularity Selectivity Optimisation
opportunities
h19 → h38 Data low (years) Coarse Low: high impact
over entire cohort
Low: entire pro-
cess disrupted
Variant caller
version change
algorithm every few months N/A High: most cases
only marginally
affected
High but straight-
forward: always
restart from vari-
ant calling
SVI Data monthly fine (individual
records)
High: most cases
unaffected, many
not significantly
affected, very few
changes in
diagnosis
High: partial,
differential re-run
possible
the dataset versions, such as those presented in Sec. 5,
making this the case study of choice to illustrate ReComp’s
capabilities. Noting that the changes only affect the SVI
portion of the pipeline, our experiments are focused on
this final part of the pipeline.
1.5. Paper Contributions
Our main and novel contribution is the specification
of a generic selective re-computation meta-process, which
harnesses an underlying Big Data process and seeks to op-
timise the extent of its re-executions in reaction to each
data change, relative to a blind re-computation baseline.
Importantly, we ensure that re-computation is lossless, i.e.
each outcome on which the change has non-zero impact is
indeed updated. The meta-process combines four basic
steps that we describe semi-formally. Within this context
we propose an algorithm to address one of the steps, scope
identification, and also observe that processes distributive
over set union and difference can effectively perform differ-
ential execution. Our second contribution is an extensive
experimental study, conducted using the SVI process as
testbed, to determine the effectiveness of the meta-process
and assess its limitations. Finally, the third contribution
is the outline of the remaining challenges in addressing re-
computation and a discussion about the ideas for a more
comprehensive technical approach.
2. A generic meta-process for selective re-
computation
As mentioned, the meta-process includes four macro
steps: (S1) computing differences between old and new
datasets that contribute to the underlying process, (S2) de-
termination of the scope of affected past executions, (S3)
identification of the fragment of the underlying process
that is affected by the change and (S4) differential execu-
tion (Fig. 4).
Figure 4: Overall design of the generic selective re-computation
meta-process.
S1: Data difference. Data differences are computed in re-
action to any data change event observed in the environ-
ment, and consist of three sets of records: added, removed
and updated. Here the main challenge is to define domain-
specific, semantically-rich differencing functions that cap-
ture only most relevant changes.
S2: Scope of change. Scope is defined relative to the pop-
ulation of outcomes from past executions, for instance a
large cohort of patients. Here the challenge is to accu-
rately identify all of the past outcomes (patient diagnoses)
that are affected by the change. In the example presented
in Tab. 1 a perfect oracle would recognise that only 14
instances of past outcomes need to be considered, namely
one instance for each ClinVar release 08/15, 10/15, 11/15
and eleven instances for ClinVar 08/16. In reality, how-
ever, it is not always possible to accurately predict which
occurrences are affected by the change as the analytics
process may implement a complex algorithm (e.g. a sim-
ulation of a physical model) or the change itself does not
provide enough context to understand its impact. But of-
ten the scope can be split into the set of clearly affected and
clearly unaffected instances, and so we can use it to reduce
the re-computation effort. To address the scope challenge,
we rely on process- and data-specific impact functions that
take data difference and past outcomes, and help eliminate
5
executions not affected by the change.
S3: Partial re-execution. If we have insight into the struc-
ture and semantics of analytics process P , we may be able
to reduce the re-computation of P to only those parts that
are located downstream from the point where the changed
dataset is first used. For this, we are inspired by techniques
for smart rerun of workflow-based applications [14, 15].
The basic requirement to support partial re-execution
is that intermediate data of every past execution be
cached, so it can be re-used in lieu of re-executing part
of a process that is known to have not been affected by
the changes. For example, if the updated data is used
only in the middle of the process we may be able to skip
processing of its initial part and use previously computed
intermediate data instead. This is much easier to achieve
in the case of scientific workflows (dataflows) such as our
NGS pipeline, where the data dependencies are explicit. In
this scenario, the main difficulty is to find a good balance
between how much intermediate data should be cached,
versus how much we should re-generate in order to min-
imise the overall re-computation cost (monetary, runtime
and/or storage). Some guidance on this topic has been
presented e.g. in [16, 17]. We present extensive experi-
ments in Sec. 7.
S4: Differential execution. Finally, the last step to opti-
mising re-computation involves the use of differences be-
tween versions of input and reference data. That is espe-
cially important in the Big Data analyses, when changes
often affect only a small part of large input data. However,
whether or not it makes sense to execute a process using
a difference rather than complete input data depends on
the function it implements.
Differential dataflows [18] is a promising approach to
realise differential execution. Depending on the amount
of change in the input data, the differential dataflows
framework8 can offer very high performance gains and
reduce runtime up to three orders of magnitude. However,
to exploit the full potential of differential dataflows in
the NGS pipeline all the algorithms used in the pipeline
would need to be rewritten following that approach –
a non-trivial task, in general. In Sec. 6 we present our
experiments and observations involving re-computation of
SVI using difference sets.
2.1. Notation
Here we provide a simple reference framework for ex-
pressing steps S1–S4 and introduce the technical elements
that underpin our experiments. Consider an instance Pi
of a deterministic analytics process P , which takes in-
put xi and produces output yi, using reference datasets
D = {D1 . . . Dm}. D is typically the same dataset across
8https://github.com/frankmcsherry/differential-dataflow
a population x1 . . . xn of inputs. For SVI, D = {OM ,CV }
consists of the two reference databases, OMIM GeneMap
and NCBI ClinVar as mentioned earlier.
The xi and yi may be tuple-valued: xi = 〈xi1 . . . xin〉,
yi = 〈yi1 . . . yim〉. We denote the types of xij (resp
yij) in each instance xi (resp yi) with Xij (resp Yij).
For instance, in SVI, patient i is represented by input
xi = 〈xi1, xi2〉 where xi1 is the list of patient variants and
xi2 is a set of phenotype terms
9. The patient’s diagnosis
is the single output yi = 〈yi1〉 = {(v, c)}, a set of variants
v along with their class label c, i.e., Green, Amber, or
Red. For simplicity of notation, and without loss of
generality, in the following we are going to refer to inputs
and outputs simply as xi, yi, and to their types as X,Y .
Data versions and change notation. Each of the
xi and Dj ∈ D may have multiple versions, which change
over time. We denote the version of xi at time t as x
t
i,
and the state of Dj at t as D
t
j . We write x
t
i → xt
′
i to
denote that a new version of xi has become available at
time t′, replacing the version xti that was current at t.
Similarly, Dtj → Dt
′
j denotes a new release of Dj at time t
′.
Executions. We denote the execution Pi of P that
takes place at time t by:
〈yti , cti〉 = exec(P, xti, Dt) (1)
where Dt = {Dt1 . . . Dtm}. cti denotes the cost of the
execution, for example a time or monetary expression
that summarises the cost of cloud resources. We also
assume for simplicity that P remains constant.
Current outcomes. Finally, by slight abuse of
notation, with Y t = {yt1, yt2 . . . ytN} we denote a set of N
outcomes that are current at time t, i.e., each yti is the
latest in a series of values yt1i . . . y
tk
i with tk ≤ t.
Impact of a change. We say that change Dtj → Dt
′
j
(resp. xti → xt
′
i ) has non-zero impact on outcome y
t iff
diff Y (y
t, yt
′
) 6= ∅, where yt′ is the new outcome computed
using Dt
′
j (resp. x
t′
i ) in (1).
2.2. Selective re-computation steps
Using this notation, we formulate steps S1–S4 as fol-
lows. Firstly, blind re-computation following a change in
a data dependency Dj : D
t
j → Dt
′
j is simply the complete
re-execution of (1) for each yt in Y t, by replacing Dtj with
Dt
′
j .
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9Phenotype is a description of patient’s disease or condition ex-
pressed using terms from a formal vocabulary, such as OMIM or the
Human Phenotype Ontology.
10Note that if the change is xti → xt
′
i , then trivially only the exe-
cutions on input xti are performed.
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S1: Diff functions. We assume one can define a family of
type-specific data diff functions, which quantify the ex-
tent of changes that occur over time in either x, Dj , or y.
Specifically:
diff X(x
t
i, x
t′
i ) diff Y (y
t
i , y
t′
i ) (2)
compute the differences between two versions of xi of type
X, and two versions of yi of type Y . Similarly, for each
source Dj ,
diff Dj (D
t
j , D
t′
j ) (3)
quantifies the differences between two versions of Dj .
The values computed by each of these functions are
type-specific data structures, and will also depend on how
changes are made available. For instance, Dtj , D
t′
j may
represent successive transactional updates to a relational
database. More realistically in our analytics setting, and
on a longer time frame, these will be two releases of Dj ,
which occur periodically. In both cases, diff Dj (D
t
j , D
t′
j )
will contain three sets of added, removed, or updated
records. The only assumption we make on these functions
is that they should all report the empty difference when
their inputs are identical: diff T (v, v) = ∅ for any type T .
S2: Identifying the scope of change. Suppose an outcome
yt is produced a Dtj which is later updated: D
t
j → Dt
′
j .
Intuitively, if exec(P, xti, D
t) has not used any of the data
in diff Dj (D
t
j , D
t′
j ), then y
t′ = exec(P, xti, D
t′) = yt, as we
have assumed that P is deterministic.
Thus, we may be able to determine with certainty, re-
quired in our lossless re-computation setting, that some of
the outcomes yt do not need re-computing, provided we
maintain a detailed account of exactly which data each
execution of P has used, from each of its external data re-
sources. Following this intuition, we address the problem
to identify the elements from a population of outcomes Y t
that are out of scope, that is, those for which re-execution
is certainly going to produce identical results given changes
in any of its data dependencies.
S3: Partial re-execution. Suppose P is specified as a work-
flow, described as a directed acyclic graph of k processing
elements P1 . . . Pk, connected through data dependencies.
Given an execution of P as in (1) and changes of the form
Dtj → Dt
′
j and/or x
t → xt′ , we want to identify the mini-
mal subset P ′ of h ≤ k processing elements in P , such that
executing P ′ using xt
′
and Dt
′
j yields the same result as
executing P entirely. Past research [14, 15] outlines con-
ditions under which effective partial execution is viable,
specifically when P has a dataflow structure.
S4: Differential execution. Given an execution of P as in
(1) and changes as above, in some cases it may be possible
to refresh an outcome yt by re-computing P using only the
differences between old and new versions of the inputs or
of the data resources. As difference sets are much smaller
than the entire inputs or reference data resources, espe-
cially in the case of Big Data problems, this may result in
significant savings in computation time.
2.3. Requirements for selective re-computation
The architectural pattern we adopt is that of a meta-
process (the ReComp process) that can provide at least two
minimal capabilities relative to an underlying process P :
• to monitor changes in the inputs, dependencies, and
outputs of P , and to quantify them, e.g. by accepting
type-specific diff X(), diff D(), and diff Y () functions,
and
• to control the partial or entire re-execution of P .
Underpinning these capabilities are a number of tech-
nical requirements regarding collecting and storing various
kinds of metadata during execution, and performing ana-
lytics on it. We specifically make use of provenance meta-
data, which the W3C defines as “information about enti-
ties, activities, and people involved in producing a piece
of data or thing, which can be used to form assessments
about its quality, reliability or trustworthiness” [19].
Specific requirements include:
• Transparency of the process structure. Ideally,
P should be a white box process, that is, it should be
possible to inspect its internal structure to support
partial and differential execution;
• Observability of process execution and prove-
nance collection. It must be possible to observe
data production and consumption events that occur
during execution, and use those to reconstruct the
provenance of the outcomes;
• Cost monitoring. Similarly, it must be possible
to assess the detailed cost (execution time, storage
volume) of each execution, as this is required to learn
estimates of the future cost of re-execution;
• Process Reproducibility Finally, it must be pos-
sible to enact a new execution of P on demand.
Not all computational models are friendly to our meta-
data analytics approach and satisfy all of the requirements
above, either because provenance collection is available but
not at the level of detail that is usable (the NoWorkflow
system [20], for instance, is very good at monitoring any
Python process but its provenance is too low-level to be
used here), or is not provided at all. In particular, black
box processes that do not reveal their internal structure,
cost, or execution provenance, such as third party web ser-
vices, are particularly hostile to our analysis.
Our experiments, however, are carried out on a plat-
form that provides ideal support for these requirements:
SVI is implemented as a workflow, providing both full
transparency and coarse-grained provenance collection and
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cost monitoring capabilities. Furthermore, the workflow is
deployed on the Azure cloud, which provides an additional
mapping of resources to price, through their cost model.
Exploring the extent to which our results deteriorate as
the requirements above are not met is currently out of our
scope.
Finally, regarding reproducibility, we note that actual
re-computation of older processes P under slightly differ-
ent conditions is not straightforward, as it may require
redeploying P on a new infrastructure and ensuring that
the system and software dependencies are maintained cor-
rectly, or that the results obtained using new versions of
third party libraries remain valid. Addressing these ar-
chitectural issues is a research area of growing interest
[21, 22, 23], but not a completely solved problem.
3. Related work
To the best of our knowledge a comprehensive solution
to re-computation of generic analytics processes in reac-
tion to changes in their input data has not been discussed
previously, and so the proposed meta-process is unique.
There exist, however, a large amount of work related to
particular steps which our re-computation meta-process
combines. We percieve this as a chance to build our sys-
tem out of existing components or at least inform our im-
plementation of them. Note, however, that the first step,
computing data difference, is rather technical and so we
focus on the other three steps of our meta-process.
The scope of re-computation. Depending on how
much insight we can have into the data analytics mod-
ules and their exact semantics, one way to partially iden-
tify scope of re-computation is to rely on fine-grained data
provenance. Known techniques of annotating data tuples
help explain why-, how- and where-provenance (see [24]
for a recent survey) and can inform why the output data
contain specific tuple and which input tuples contributed
to produce it. While this is not enough to understand how
new tuples would affect the output, it may still be useful to
determine impact of changed and removed records. Specif-
ically, provenance enables us to discover the subset of all
input records involved in producing the output, and so a
change in any of these records directly indicates impact.
Despite this being a generic and application-
independent mechanism, however, two issues make it hard
to use data provenance to implement impact functions.
Firstly, in general we consider black-box analytics modules
which not necessarily follow well understood semantics of
the select, project and join operators. Secondly, our expe-
rience with genomics databases shows that changes usu-
ally involve all three types of added, removed and changed
records, which limits the use of the existing data prove-
nance techniques and makes impact analysis more diffi-
cult.
For these reasons, we have chosen to use difference
functions and the coarse-grained provenance information
to determine the scope of re-computation. Note that this
a technical aspect is novel and not well covered in the lit-
erature.
Partial process re-execution has been studied ex-
tensively in the past. Perhaps the best known tool for
automated re-execution of programs in reaction to any
changes in their dependencies is Make.11 The tool helps
control the build process of a program from the program’s
source code. Its key feature is the ability to generate a
dependency graph between source files, intermediate ar-
tifacts and outputs such that a change in one source file
results in a partial rather than complete rebuild of pro-
gram sources. To drive partial rebuild, Make simply uses
the file modification date. Whenever any of the prerequi-
site files has a date newer than the target file, the relevant
rule is fired off and the target file is rebuilt.
Two techniques for smart rerun, SRM, and partial pro-
cess re-execution, in SPADE, are closely related to our
work. Smart Rerun Manager (SRM) [14] is part of the
Kepler WFMS. The idea of smart rerun of a workflow,
previously explored by the same group [25], is to react
to changes in one or more parameters in a workflow ac-
tor by only executing those parts of the workflow that
are affected by the changes, taking data dependencies into
account. The approach relies on coarse-grain provenance
traces and intermediate data collected and stored during
workflow execution, and is derived from a similar approach
implemented in VisTrails [26]. In principle, the interme-
diate results of workflow execution are extracted from a
cache instead of being recreated by re-enacting the work-
flow.
Each intermediate data product is assigned a unique
ID in the cache. The provenance trace is traversed from
the end of the execution back to the start. For each actor
found during the traversal, SRM checks whether the data
products generated by this actor are still valid, i.e. are
found in the cache. If that is the case, then the entire
subgraph that ends with that actor does not require re-
execution. In this case, the cached data is used from that
point onwards.
SPADE recently implemented partial process re-execu-
tion [15]. The framework can capture fine-grained system-
level provenance information and can later use it to im-
prove effectiveness of process re-execution. By intercept-
ing the low-level system calls, SPADE can recreate a DAG
structure of the process even without explicit workflow
specification. The basis of building the acyclic data de-
pendency graph is versioning of the data artifacts. If a
task within the process reads and writes to a file, every
write generates a new version of the file which can poten-
tially be reused during re-execution and rollback.
Our approach to partial re-execution is similar to both
SRM and SPADE. We collect provenance of workflow-
based applications like SRM does, whilst to calculate the
minimal re-computation subgraph we use the data ver-
sioning mechanism provided by e-SC, which is closer to
11http://www.gnu.org/software/make
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file versioning in SPADE. Also similar is that to store
provenance information we use the PROV and ProvONE
models, which are successors of the OPM model used by
SPADE. Although the idea is not new, ours is the first
implementation to operate off the e-SC workflow model,
and it plays only a partial role in a more ambitious pic-
ture, where we seek to prioritise re-execution within a large
collection of prior outcomes.
Techniques for differential execution such as incre-
mental computation [27, 28] address the problem of re-
acting effectively to incremental changes in the program’s
input data. Briefly, these techniques are based on de-
pendency graphs, memoisation and partial evaluation –
concepts similar to what we use to re-compute our pro-
cess, yet applied on the scale of a single algorithm or pro-
gram. A number of incremental computation solutions
has also been applied to Big Data problems. Most no-
table are DryadInc [29], Haloop [30] and Incoop [31] and
more recently iiHadoop [32]. Again, the main difference
between these and our approach is that we consider re-
computation in broader sense, not limited to only a sin-
gle algorithm or execution for which input data has been
updated. Instead, by combining all four steps we can ad-
dress the problem of selective re-computation in a com-
prehensive way and across many separate executions. The
problem we address is to effectively reduce the number of
past executions which need re-computation and also the
amount of processing a single data update requires. This
does not prevent the use of other incremental techniques,
e.g. differential dataflows [18], iiHadoop or parallel incre-
mental computation implemented in iThreads [33], as the
basis for re-execution.
4. Experimental setting and blind re-computation
baseline
Our experiments are based on the SVI tool, which is a
natural continuation of the more complex variant calling
NGS pipeline. SVI is much less resource-intensive and thus
easier to work with than the complete pipeline. At the
same time, it exhibits many features of the larger process:
its reference databases are updated frequently and it may
be run over a cohort of patients, thus it provides a very
realistic example how evolving input data may influence
patient’s diagnosis.
4.1. The SVI workflow
SVI is implemented using the same workflow technol-
ogy , namely the e-Science Central (e-SC) platform [34],
a cloud-based Workflow Management System designed for
scientific data management and analysis. A screenshot of
the SVI implementation in e-SC is shown in Fig. 5. To re-
call, e-SC supports a simple dataflow programming model
where processing blocks are connected to each other using
data links, in a DAG topology. Our performance analy-
sis of the variant calling workflow is described in detail
elsewhere [4].
The choice of using e-SC as a platform for our experi-
ments satisfies all of the requirements listed above. Firstly,
workflows are white box processes, where the partial re-
execution problem translates into a problem of selecting a
suitable sub-graph from the whole workflow DAG struc-
ture.
Secondly, e-SC automatically records the derivation
history of every workflow output from the inputs, i.e. their
provenance. The provenance traces are described using
the ProvONE data model [35], which extends the stan-
dard PROV data model [19]. For the purpose of human-
readable description, in this paper we use the PROV-N no-
tation [36] to present relevant provenance fragments. This
includes details required for re-execution, such as the pa-
rameter settings for the processing blocks, and the version
of each library and data dependency at the time of execu-
tion.
Thirdly, detailed execution costs at the level of the sin-
gle processing block, as well as data storage costs, are avail-
able either through e-SC or the underlying cloud deploy-
ment (Azure, in this instance). Finally, the dependency
manager that oversees the execution of e-SC workflows
provides the required levels of reproducibility, i.e. the abil-
ity to re-run old workflows on demand. This rich corpus
of metadata enables the kind of analysis required by our
techniques, for instance estimating the cost of selecting a
particular sub-graph for partial workflow re-execution.
4.2. Data changes considered in the experiments
As mentioned in the introduction, for each patient SVI
uses two kinds of data: the case-specific patient variant
file and phenotype, and two external reference databases:
OMIM GeneMap to find genes relevant to the given phe-
notype hypothesis, and NCBI ClinVar used to interpret
the pathogenicity of patient variants.
Changes to the reference databases are very relevant
because they often affect a large number of patients and
are the primary cause of knowledge decay. Furthermore,
the SVI reference databases change frequently, providing a
good time granularity for experiments: GeneMap updates
are published every day, whereas new ClinVar versions are
announced every month.
In contrast, changes to patient phenotype are not con-
sidered because those represent a change, initiated by a
clinician, in the actual disease hypothesis, and this au-
tomatically triggers a new investigation for the patient.
Similarly, we do not consider updates to the patient vari-
ants, because those change infrequently and not enough
data points would have been available in our test dataset.
4.3. Experimental setup
For the purpose of this study, SVI was run on a small-
scale deployment of the e-Science Central system in Mi-
crosoft Azure, consisting of the e-SC server running on a
Basic A2 VM (2 CPU-cores, 3.5GB RAM) and of a single
workflow engine, hosted on a Basic A3 VM (4 CPU-cores,
7 GB RAM). Both ran Ubuntu 16.04 OS.
9
Figure 5: The SVI tool implemented as an e-Science Central workflow.
We used patient variants files with three phenotypes:
Alzheimer’s disease, Frontotemporal dementia – Amyotro-
phic lateral sclerosis and CADASIL syndrome. On average
they included 24 thousand records, around 39 MB in size.
The OMIM GeneMap reference database was accessed on
31/Oct/2016 (unless stated otherwise) and a range of ver-
sions of NCBI ClinVar database were used, from July 2015
to October 2016. For more details about the patient vari-
ant files and reference databases please refer to Tab. A.6
and A.7 in Appendix A.
4.4. Baseline: blind re-computation
As mentioned in the introduction, blind re-computation
refers to the baseline case where any change at all in any
of the reference databases triggers a full re-computation of
the entire population of prior outcomes. Tab. 1 shows the
effects of reacting to new versions of ClinVar regardless of
the extent of the changes between any two versions. The
Table reports results from nearly 500 executions, concern-
ing a cohort of 33 patients, for a total runtime of about
58.7 hours. As merely 14 relevant output changes were de-
tected, this is about 4.2 hours of computation per change:
a steep cost, considering that the actual execution time of
SVI takes a little over seven minutes.
Furthermore, the table only portrays a partial picture,
as it only includes reactions to monthly changes in Clinvar.
A really blind approach would also react to daily changes
to GeneMap, which are shown to have very little effect on
the outcomes. For instance, comparing outputs generated
using the same version of ClinVar and four consecutive
versions of GeneMap: 16-10-30, 16-10-31, 16-11-01 and 16-
11-02 shows that none of the patient variants was affected
at all by these small changes.
The sparsity of the table should come as no surprise,
as changes in the reference databases are dispersed across
the whole human genome and so the chance that they may
affect a particular patient are relatively small. Further de-
tails on these experiments can be found in supplementary
material sheet CV-blind.
In the next sections we discuss in detail the re-
computation meta-process applied to our model analyt-
ics process SVI. We start from computing data differences
(S1) and then grow the amount of processing going back-
wards from experimenting with differential execution (S4),
to applying partial re-execution (S3), up to identification
of the scope of change (S2). As a result, our final exper-
iment includes a realisation of the re-computation meta-
process for the SVI tool with steps S1–S3 applied.
5. Data differences
The reference databases that SVI uses are in the
“well-behaved” category of simple relational tables,
making it easy to express differences in terms of set
operations. Specifically, the added and removed subsets
are just set difference between two versions, while the
changed subsets are an intersection followed by a selection.
The following SQL-like pseudocode specifies these opera-
tions more formally on two versions D1, D2 of a data table:
ADDEDD1→2 = select * from D2
where not exists (
select 1 from D1
where D1.KEY = D2.KEY
)
REMOVEDD1→2 = select * from D1
where not exists (
select 1 from D2
where D1.KEY = D2.KEY
)
CHANGEDD1→2 = select D2.* from
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D1 inner join D2 on D1.KEY = D2.KEY
where D1.NON-KEYc1 <> D2.NON-KEYc1 or
D1.NON-KEYc2 <> D2.NON-KEYc2 or ...
These operators assume that we have selected key at-
tributes (possibly compound) for D. Also, CHANGEDD1→2
denotes the new version of the updated records, whereas
analogous CHANGEDD2→1 is used to compute the old version
of the updated records. In effect:
δ+ = ADDEDD1→2 ∪ CHANGEDD1→2
δ− = REMOVEDD1→2 ∪ CHANGEDD2→1
Note that the CHANGED operator captures all chan-
ges in any of the non-key attributes for each record. While
this is generic, it ignores the meaning of the attributes
relative to the specific processing and is likely to result
in a large number of changes irrelevant to the process.
For example, two GeneMap records that differ only in the
Comments attribute would be flagged as different, although
the comments are not used anywhere in SVI. Similarly, the
only changes in ClinVar records that are relevant to SVI
are those in the ClinicalSignificance attribute, which
drive the classification of variants in the SVI output.
Thus, with the knowledge of the specific use of a re-
lational dataset that the process makes, we partition the
attributes into the KEY, USED, and UNUSED datasets.
The CHANGED operator can then be rewritten as:
CHANGEDD1→2 = select D2.* from
D1 inner join D2 on D1.KEY = D2.KEY
where D1.U1 <> D2.U1 or
D1.U2 <> D2.U2 or ...
where Ui ∈ USED.
There is an obvious benefit in efficiency resulting from
this more aggressive filtering of the difference sets, as illus-
trated in Tables 3 and 4. The tables report on the number
of records of the complete GeneMap and ClinVar datasets
and the difference sets calculated using the generic and
SVI-specific diff operators. Using the SVI-specific oper-
ators the reduction in size is almost always about 90%
or over. The only exceptions are the differences between
version Jul→Aug 2015 of ClinVar which faced a signifi-
cant change at the time. Then, the SVI-specific operator
yielded a reduction of 49.6%.
More limited gain is achieved when using the generic
diff operators. In three cases the total size of the dif-
ference sets was larger than the new version of the Clin-
Var database. Similarly, the differences between GeneMap
16-06-07 and 16-10-30 computed by the generic opera-
tors were only 24.7% smaller than the new version of the
database. Clearly, in such cases it is more effective to ig-
nore the difference sets and use only the new version of
the data.
Another important aspect of calculating the difference
sets is the changing set of attributes. For example, the
ClinVar attributes have changed three times since Febru-
ary 2015. These changes in the schema disrupt our dif-
ference operators because the three sets KEY, USED,
UNUSED change, and also they are no longer perfectly
aligned across versions. Therefore, in our implementation
of ClinVar diff we assumed that we would compare only
columns common in both versions and ignore the added
and removed columns. Currently, our SVI re-computation
supports any version of ClinVar since Feb 2015.
6. Differential execution
Given the difference sets of the changed inputs we can
look at re-execution of P using merely diff D(d
t, dt
′
) – the
differences between two versions of (one or more) refer-
ence dataset D. Some of these ideas are grounded in prior
research on the incremental computation and differential
computation domains [37, 18].
Using SVI as our testbed, we show that under some
conditions this is feasible to do and results in substantial
savings. However, in the general case P requires modifi-
cations in order to yield a valid result.
6.1. Computing on data versions differences
To make the idea precise consider our baseline execu-
tion (1):
〈yt, ct〉 = exec(P, xt, Dt) (4)
We are now going to focus on changes to D, thus we as-
sume xt is constant over time: xt
′
= xt = x (in SVI, this
means we consider one patient at a time). For simplicity of
exposition, initially we also assume a single D with states
Dt, Dt
′
. In the common case where D is a relation and
Dt consists of a set of records, such as a CSV-formatted
file (the case for ClinVar), we can express diff D(D
t, Dt
′
)
in terms of set differences:
diff D(D
t, Dt
′
) = 〈δ+, δ−〉
where:
Dt
′
= Dt \ δ− ∪ δ+ (5)
and δ+ denotes the added records and new version of up-
dated records whilst δ− are records removed from Dt and
the old version of the records that are going to be updated.
Note that in the case of ClinVar and most bioinformatics
databases, δ− include retractions, which are much less fre-
quent than additions of new records.
Our contention is that the computation of new outcome
〈yt′ , ct′〉 = exec(P, x,Dt′) (6)
can be broken down into two smaller computations that
only use δ+, δ− and produce partial outcomes yt
′
+, y
t′
−,
which can then be combined with yt to yield yt
′
. This may
11
Table 3: The number of records and reduction percentage of the generic and SVI-based difference sets calculated for selected versions of
OMIM GeneMap. Highlighted is less favourable size reduction of the sets.
|ADDED|+ 2 · |CHANGED|+ |REMOV ED| Reduction (%)GeneMap versions
Dold → Dnew |Dnew|
generic δ SVI-specific δ 1− |δgen||Dnew| 1−
|δSV I |
|Dnew|
16-04-28 → 16-06-01 15897 27 + 196 + 1 = 224 27 + 142 + 1 = 170 98.6 98.9
16-06-01 → 16-06-02 15897 0 + 8 + 0 = 8 0 + 4 + 0 = 4 99.95 99.97
16-06-02 → 16-06-07 15910 13 + 76 + 0 = 89 13 + 52 + 0 = 65 99.4 99.6
16-06-07 → 16-10-30 16031 128 + 11944 + 7 = 12079 128 + 636 + 7 = 771 24.7 95.2
16-10-30 → 16-10-31 16031 0 + 10 + 0 = 10 0 + 8 + 0 = 8 99.94 99.95
16-10-31 → 16-11-01 16031 0 + 42 + 0 = 42 0 + 0 + 0 = 0 99.7 100.0
16-11-01 → 16-11-02 16031 0 + 4 + 0 = 4 0 + 0 + 0 = 0 99.98 100.0
16-11-02 → 16-11-30 16063 34 + 186 + 2 = 222 34 + 138 + 2 = 174 98.6 98.9
require an additional merge(·) function that is process-
specific. More precisely, we break (6) down into:
〈yt′+, ct
′
+〉 = exec(P, x, δ+) (7)
〈yt′−, ct
′
−〉 = exec(P, x, δ−) (8)
〈yt′ , ct′m〉 = merge(yt, yt
′
+, y
t′
−) (9)
This breakdown is beneficial if the resulting total cost is
less than ct
′
:
ct
′
+ + c
t′
− + c
t′
m < c
t′
Firstly, let us consider the case in which P imple-
ments a “well-behaved” function that is distributive over
set union and difference. Using (5) and (6) and ignoring
cost for the time being, we can write:
yt
′
= exec(P, x,Dt
′
)
= exec(P, x,Dt \ δ− ∪ δ+)
= exec(P, x,Dt) \ exec(P, x, δ−) ∪ exec(P, x, δ+)
= yt \ yt′− ∪ yt
′
+
(10)
Thus, in this case, yt
′
+, y
t′
− can be automatically com-
bined into yt
′
. However, distributivity is a strong assump-
tion, which does not hold for many practical cases. For
example, SVI as a whole distributes only over set differ-
ence and union of selected inputs. But in the general case,
P may need to be modified in order to combine the partial
results using an ad hoc merge function.
To illustrate this situation note that SVI essentially
consists of four steps (cf. Fig. 2):
a) SELECTION operation that selects from GeneMap
only genes relevant to user-defined phenotype ph,
producing genes in scope GS :
GS = σph(GeneMap)
b) INNER JOIN operation between the input variants,
x, and the result of the previous query GS , produc-
ing variants in scope VS :
VS = x on GS
c) RIGHT OUTER JOIN to combine pathogenicity an-
notations from ClinVar with corresponding VS yield-
ing VSp:
VSp = ClinVar ./ VS
d) final classification into the traffic light system, which
adds new classification column to VSp:
classify(VSp)
Given these steps, SVI is specified by the following ex-
pression:
SVI (x, ph,GeneMap,ClinVar) =
classify(ClinVar ./ (x on σph(GeneMap)))
Note, however, that (a), (b) and (d) are all distributive
over set union and difference, whereas (c), the right outer
join, distributes only for the right-hand side argument.
Therefore, we can automatically combine partial outcomes
when δ+ and δ− are computed for GeneMap, GS , x, VS , or
VSp , whilst differences in ClinVar require a custom merge
function.
Regarding GeneMap, the computation steps are as fol-
lows. Let
yt = SVI (x, ph,GMt,CV)
be the original computation, and
GMt
′
= GMt \ δ− ∪ δ+
be a new version of GeneMap, expressed in terms of version
differences. The new yt
′
can be computed as:
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Table 4: The number of records and reduction percentage of the generic and SVI-based difference sets calculated for 16 versions of ClinVar.
Highlighted are less favourable size reductions of the sets.
|ADDED|+ 2 · |CHANGED|+ |REMOV ED| Reduction (%)ClinVar versions
Dold → Dnew |Dnew|
generic δ SVI-specific δ 1− |δgen||Dnew| 1−
|δSV I |
|Dnew|
15-07 → 15-08 252656 35087 + 425794 + 85987 = 546868 35087 + 6302 + 85987 = 127376 −116.4 49.6
15-08 → 15-09 259714 7273 + 16952 + 215 = 24440 7273 + 1342 + 215 = 8830 90.6 96.6
15-09 → 15-10 262498 2832 + 11888 + 53 = 14773 2832 + 1174 + 53 = 4059 94.4 98.5
15-10 → 15-11 277902 15550 + 108588 + 146 = 124284 15550 + 4300 + 146 = 19996 55.3 92.8
15-11 → 15-12 279174 1376 + 489530 + 104 = 491010 1376 + 472 + 104 = 1952 −75.9 99.3
15-12 → 16-01 280379 1523 + 23740 + 318 = 25581 1523 + 2224 + 318 = 4065 90.9 98.6
16-01 → 16-02 285041 4710 + 26304 + 48 = 31062 4710 + 1490 + 48 = 6248 89.1 97.8
16-02 → 16-03 286684 2477 + 235330 + 453 = 238260 2477 + 2510 + 453 = 5440 16.9 98.1
16-03 → 16-04 290432 3855 + 27088 + 107 = 31050 3855 + 1282 + 107 = 5244 89.3 98.2
16-04 → 16-05 290815 858 + 15732 + 475 = 17065 858 + 1158 + 475 = 2491 94.1 99.1
16-05 → 16-06 306503 18004 + 81738 + 2298 = 102040 18004 + 7174 + 2298 = 27476 66.7 91.0
16-06 → 16-07 320469 14496 + 56692 + 530 = 71718 14496 + 6696 + 530 = 21722 77.6 93.2
16-07 → 16-08 326856 6558 + 58238 + 174 = 64970 6558 + 31356 + 174 = 38088 80.1 88.3
16-08 → 16-09 327632 1020 + 18838 + 244 = 20102 1020 + 1104 + 244 = 2368 93.9 99.3
16-09 → 16-10 349074 22758 + 654486 + 630 = 677874 22758 + 13228 + 630 = 36616 −94.2 89.5
yt
′
= SVI (x, ph,GMt
′
,CV)
= classify(CV ./ (x on σph(GMt
′
)))
= classify(CV ./ (x on σph(GMt \ δ− ∪ δ+)))
= classify(CV ./ (x on (σph(GMt) \ σph(δ−)
∪ σph(δ+))))
= classify(CV ./ ((x on σph(GMt))
\ (x on σph(δ−)) ∪ (x on σph(δ+))))
= classify(CV ./ (x on σph(GMt)))
\ classify(CV ./ (x on σph(δ−)))
∪ classify(CV ./ (x on σph(δ+)))
= SVI (x, ph,GMt,CV)
\ SVI (x, ph, δ−,CV) ∪ SVI (x, ph, δ+,CV)
= yt \ yt′− ∪ yt
′
+
(11)
Although the same approach does not work for changes
in ClinVar, we can still adapt SVI and define a bespoke
merge() function to combine partial results in a way that
is semantically meaningful for the specific data and pro-
cess. An implementation of such a function would filter
the results from the right outer join yt
′
− and y
t′
+ by remov-
ing rows with null in ClinVar columns, essentially turning
right outer join into inner join:
zt
′
− = filter(y
t′
−) z
t′
+ = filter(y
t′
+) (12)
Then, using the filtered products it performs spe-
cialised set operations:
yt
′
= yt ∪
amb
zt
′
− ∪wrt zt
′
+ (13)
where a ∪
amb
b sets the classification to amber for all rows
in a that match b, whereas a ∪
wrt
b overwrites the classi-
fication for all rows in a that match b on non-ClinVar
columns; both operations leave non-matching rows intact.
Given definitions (12) and (13), we can define the spe-
cialised merge function as:
mergeSVI (y
t, yt
′
+, y
t′
−) =
yt ∪
amb
filter(yt
′
−) ∪wrt filter(yt
′
+)
(14)
As we can see, this approach may need a substantial
amount of process refactoring and makes the definition of
merge encode some of the process semantics to operate on
data differences. Nevertheless, in the rest of this section
we are going to illustrate the practical steps in computing
the differences δ+, δ− and the partial outputs yt
′
+ and y
t′
−
on SVI, which will be useful to address the scope analysis.
6.2. Re-computation using the difference sets
To see the effect of using the difference sets on runtime
we executed SVI with the range of GeneMap and ClinVar
difference sets shown in Tab. 3 and 4. Note that in the
case of ClinVar differences we did not include the merge
function defined earlier in (14). However, doing so would
not affect the runtime significantly as the SVI outputs con-
tain only about a dozen rows. Fig. 6 shows the execution
times.
Interestingly, the results indicate two very distinct
cases. First, using the difference sets to calculate the out-
put yields clear runtime savings for changes in ClinVar.
Re-computation time oscillated around 100 seconds with
the only exception for the considerable changes between
13
0100
200
300
400
500
600
700
800
900
Ex
ec
u
ti
o
n
 t
im
e 
[s
]
GeneMap update date
0
100
200
300
400
500
600
700
800
900
08/15 09/15 10/15 11/15 12/15 01/16 02/16 03/16 04/16 05/16 06/16 07/16 08/16 09/16 10/16
Ex
ec
u
ti
o
n
 t
im
e 
[s
]
ClinVar update date
GM subgraph w. SVI-diff CV subgraph w. SVI-diff blind
Figure 6: The re-computation time of the SVI workflow using the difference sets following changes in GeneMap (left; ClinVar version 16-08)
and ClinVar (right; GeneMap version 16-10-31).
the July and August 2015 versions of the database (cf.
Tab. 4). However, using the GeneMap difference sets we
observed loss in the execution time in most cases. Even
if the changes were minimal (e.g. 16-06-01→16-06-02 and
16-06-02→16-06-07) and the difference sets contained only
a few records, re-execution took about 400 seconds for δ+
and δ− separately; over 800 seconds altogether. In two
cases we could skip re-execution because the difference sets
were empty.
That problem with GeneMap differences stems from
the fact that this database is nearly two orders of mag-
nitude smaller than ClinVar. Therefore, the majority of
runtime is spent on tasks processing ClinVar whilst the
smaller GeneMap file does not affect overall execution
time that much. We observed some savings only for two
blocks: the WHERE and JOIN located at the front of the
pipeline. But the remainder of the pipeline used the com-
plete ClinVar database. Conversely, when ClinVar under-
goes changes, the data is used by SVI at the tail of the
pipeline where the longest running JOIN block is located
(cf. Fig. 8). Thus, using the difference sets rather than the
complete version of ClinVar, we could lower the runtime
of that block significantly and reduce the total execution
time of the relevant workflow subgraph.
Overall, even if the use of difference sets can reduce
runtime of a single execution to some extent, the savings
depend on the structure of the process and may not be
enough to compensate for the fact that two executions are
needed – one for δ+ and one for the δ− difference set.
7. Partial re-execution
The third step in our re-computation model is partial
re-execution. As shown earlier in Fig. 4, to implement
it we do not require the actual difference data but only
information about the data dependencies. In Sec. 4.1 we
mentioned that e-SC generates one ProvONE-compliant
provenance trace for each workflow run. We exploit these
traces to identify the minimal sub-workflow that is affected
by the change [14, 15].
Suppose we record a change of the form dt → dt′ in ref-
erence data, and let I be a past invocation of our workflow.
The source blocks for any sub-workflow that is affected by
the change are those activities A that were executed as
part of I and that used dt directly. These can be obtained
from the query:
:- wasPartOf(A, I), used(A, dt)
Note that the change event itself can be recorded using
a provenance assertion:
wasDerivedFrom(dt
′
, dt)
In this case, the query becomes:
:- wasDerivedFrom(dt
′
, D), wasPartOf(A, I),
used(A,D)
where D is now a variable that represents the previous
version of dt
′
.
Having determined the source blocks, we expand the
workflow recursively, by traversing the provenance graph
for invocation I, downstream. At each step we seek two
possible patterns:
1. execution(A1), execution(A2), wasInformedBy(A2,
A1): given A1, find all activities A2 that have
been triggered by A1. This pattern represents a
connection from A1 to A2, where the intermediate
data that flows over the link during execution is
implicit;
2. execution(A1), execution(A2), wasGeneratedBy(D,
A1), used(A2, D): Here the dependency between A1
and A2 is represented explicitly by the intermediate
data product, D.
Fig. 7 shows the sub-workflows related to a change in
GeneMap (blue area) and ClinVar (red area). The black
arrows on the left indicate the starting blocks for the sub-
workflows. The overlapping area between the two sub-
workflows contains the blocks that are affected by either
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Figure 7: The illustration how retrospective provenance trace of a complete execution can be used to calculate the cost of partial execution;
the black arrow at the top-left corner indicates the starting block; the red circle indicates the required intermediate data; red numbers in the
workflow blocks denote execution time in seconds.
of the two changes. Clearly, a partial execution following
a change in only one of the databases requires that the
intermediate data at the boundary of the blue and red
areas be cached.
To provide a measure of the trade-off between addi-
tional space requirements and the savings in execution
time, we have annotated the figure with the execution
time (in seconds) for each of the blocks, and with the
size of the cached intermediate data. For example, for
a GeneMap change, the corresponding partial execution
took about 325 seconds (or 5m:25s), whereas a ClinVar
change required 287 seconds (or 4m:47s) to re-execute.
Recalling that the cost of a complete execution was 455
seconds (or 7m:35s), these are savings of 28.5% and 37%,
respectively. The corresponding additional storage costs
are 156MB and just 37KB, resp. The complete results of
the partial re-computation following changes in the ref-
erence databases are included in supplementary material
sheets CV-subgraph and GM-subgraph.
We note that these figures are obtained from the prove-
nance traces, namely using the standard prov:startTime
and prov:endTime properties of activity, along with an addi-
tional recomp:dataSize property, which we added to record
the size of the entities transferred between blocks.
Fig. 8 provides an alternative view of a possible sched-
ule for the same workflow, which shows the parts of the
workflow affected by each of the changes, along with the
rendering of the execution times and amount of data in-
volved. We can see that a change in ClinVar affects only
a sub-workflow starting in the middle of the workflow,
whereas a change in GeneMap affects almost all of the
blocks. However, both sub-workflows include the longest
running block, which limits the amount of savings that can
be achieved.
8. Identifying the scope of change
We now can address the second step (S2) from Sec. 2,
namely how to identify the scope of a change in reference
data D that is used to produce a large population, Y , of
outcomes [3]. As mentioned, SVI is once again a good case
study for this problem as the same process is executed over
a possibly large cohort of patients (thousands). Whilst
these executions are all independent of one another, they
all depend on the same reference datasets. The scope of a
change in any of these dependencies D is subset Ys ⊆ Y
of outcomes affected by change Dt → Dt′ .
Provided that diff D(D
t, Dt
′
) includes only changed
and removed records and the process consist of a set of
known transformations, fine-grained provenance solutions
such as [38, 39, 40] can help identify whether or not y ∈ Ys.
Briefly, fine-grained data provenance enables both forward
and backward queries. A forward query φ(i) retrieves the
output records that are associated by derivation to an in-
put record i, while a backwards query traces the input
records that contributed to a given output. Thus, given
δ− and assuming that ADDEDDt→Dt′ = ∅, the problem of
finding whether y ∈ Ys can be formulated using the for-
ward query φ as follows:
y ∈ Ys ⇐⇒ ∃i ∈ δ− : φ(i) ∩ y 6= ∅ (15)
Effectively, the forward query φ plays the role of an in-
dexing mechanisms that maps input records to the outputs
they contributed to. There are two main limitations of this
approach, however. Firstly, the fine-grained data prove-
nance is unable to handle newly added records, because
there is simply no provenance trace about these records
until the process runs and produces the output. Secondly,
while fine-grained provenance can capture a rich set of
transformations used in practice (see, e.g. [41, 40]), it will
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Figure 8: One of the possible schedules of the SVI workflow tasks; wider arrows denote more data flowing between tasks; numbers in boxes
represent task execution time in seconds (ClinVar v=16-09, GeneMap v=16-10-31, PV=B 0201).
not be available for black-box analytics processes that do
not reveal their internal sub-processes. In this case, prove-
nance will naively report that all input records contributed
to produce each output record, with a trivial scope that
includes all outputs.
A possible statistical approach to establishing whether
y ∈ Ys with some confidence is to sample a number of
prior y from Y , compute the corresponding y′, and use
the differences diff Y (y, y
′) to try and learn an estimator
for the differences on the unobserved new outcomes. This
approach, however, is likely to be sensitive to the specific
types of data and process involved and may not always
yield robust estimators.
8.1. The basic scoping algorithm
Instead, we propose a scope determination algorithm
that relies on the coarse-grained provenance associated
with past runs to determine which outcomes y have used
a version of D. Coarse-grained provenance, however, only
indicates whether or not a dependency on D existed, but
not which specific data from version Dt of D was used.
It is, therefore, possible that an outcome y that depended
on D is not really in the scope of change Dt → Dt′, for
instance because the process used data from Dt that has
not changed in Dt
′
. These are candidate invocations which
must be further analysed to determine the actual impact
of change on each of them.
To carry out this analysis further, we propose to re-
execute P one task at a time using the difference sets (δ−
and δ+). We first consider the case in which the tasks of P
are distributive over set union and difference, as described
in (10) and (11). Then, we can execute the tasks one at a
time until either we observe an empty result or we reach
the end of the process. In the former case we know that
the invocation was out of scope and no full re-execution is
needed. In the latter case we can combine the original out-
put with the final δ− and δ+ to obtain the updated result
of P (Dt
′
). Clearly, this approach is beneficial if computing
P on the difference sets is faster than computing P using
the entire Dt
′
. Algorithm 1 formalises this approach.
Procedure SelectiveExec takes process P and two ver-
sions of its input data together with the coarse-grained
provenance information represented by history database
H. First, difference sets δ+ and δ− are computed be-
tween the two versions of the input data (line 2). H is
then queried in line 3 to find occurrences of statements of
Algorithm 1 Simple selective re-computation of a popu-
lation of invocations of the process that is distributive over
set union and difference.
1: procedure SelectiveExec(P , Dt, Dt
′
, H)
2: 〈δ+, δ−〉 = diff D(Dt, Dt
′
)
3: I ← ListInvocations(H, P , Dt)
4: for all I ∈ I do
5: G← MinimalSubgraph(I, Dt)
6: while G 6= ∅ and (δ+ ∪ δ−) 6= ∅ do
7: task ← Pop(G)
8: δ+ ← task(δ+)
9: δ− ← task(δ−)
10: end while
11: if G = ∅ then
12: y ← GetOutput(task)
13: SetOutput(P , Dt
′
) ← y \ δ− ∪ δ+
14: else
15: y ← GetOutput(P , Dt)
16: SetOutput(P , Dt
′
) ← y
17: end if
18: end for
19: end procedure
form:
used(a,Dt),wasPartOf(a, I), wasAssociatedWith(I, , P )
indicating that Dt was used by a specific activity a that
was part of execution I of process P , or
used(I,Dt),wasAssociatedWith(I, , P )
indicating, more broadly, that Dt was used at some un-
specified point during I. In both cases the provenance
traces identify the set of candidate invocations.
Each of these candidate invocations is then re-executed
using the difference sets (loop in lines 4–14). To do it
efficiently the algorithm computes the minimal subgraph of
I that needs re-computation (line 5), as discussed earlier in
Sect. 7; for SVI it is one of the subgraphs shown in Fig. 7.
The inner loop in lines 6–10 walks through each task of the
minimal downstream graph (in topological order) and re-
executes the task using the difference sets until either both
partial outputs are empty or all tasks have been visited.
Assuming that the tasks are distributive under set union
and difference, the latter case allows us to generate output
of P (Dt
′
) using the previous output and partial outcomes
of the last task of P (lines 12–13).
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For simplicity of presentation the presented algorithm
can only work for a linear graph of tasks. Nonetheless,
making it work for an arbitrary directed acyclic graph with
multiple entry points for Dt is a straightforward extension.
8.2. Practical realisation of scoping
The main limitation of Alg. 1 is that it may only be
applied across tasks that distribute over set union and dif-
ference. That is a strong assumption which is challenging
even for a simple example like SVI. Likewise, it is chal-
lenging in the much more complex case of NGS pipelines
in which the alignment tools (e.g. bwa, samtools) need
access to the complete human reference genome. They
cannot perform sequence realignment if given only a differ-
ence between two versions of the reference genome. Thus,
to benefit from this algorithm in practice we extended it
to allow more diverse process tasks.
Algorithm 2 presents the inner while loop which in-
cludes a set of additional checks to make sure that only
tasks which can use difference sets properly are consid-
ered. Lines 9–11 handle the case from Alg. 1 – distributive
tasks. Then, in lines 12–15, the algorithm tries to use the
incrementalised version of a task if one is available. That
might handle the non-distributive right outer join in SVI
following an approach proposed e.g. by [42]. However, as
implementing an incremental version of a task is known to
be a difficult problem in general, our algorithm includes
one more case which we explore in more detail below.
Lines 17–27 handle all other tasks for which we first
obtain an impact function. The impact function cannot
compute the actual output of the task given its partial
input δ− and δ+. It can, however, determine whether
the partial input is likely to affect output y of the task.
Briefly, the impT function returns true to denote that the
partial input has non-zero impact on the output, and false
otherwise. Given that, if the function returns true, the
algorithm returns the current task back to the front of G
and re-executes the subworkflow using the complete past
input of the task (lines 20–23). Afterwards the algorithm
is completed and we can return from the procedure.
In the case there is no impact of partial input on the
task output we make sure G is non-empty and break the
inner loop (lines 25–26). Consequently, the procedure can
set the output of P (Dt
′
) using the previous workflow out-
put (Alg. 1, lines 14–16).
Although for all tasks that cannot work with partial
inputs the proposed algorithm forces us to use an impact
function, in the simplest default implementation it may
always return true to indicate that any change in the input
affects the output. That is likely to result in more re-
computation than needed but allows any arbitrary task to
be handled correctly while giving chance to provide impact
functions whenever possible. For example for SVI and the
problematic right outer join we were able to use inner join
as an accurate impact function.
Algorithm 2 An extension of the selective re-
computation over the executions dimension to handle var-
ious types of computing tasks. The while loop in Alg. 1
may be changed as follows.
6: . . .
7: while G 6= ∅ and (δ+ ∪ δ−) 6= ∅ do
8: task ← Pop(G)
9: if IsDistributive(task) then
10: δ+ ← task(δ+)
11: δ− ← task(δ−)
12: else if IsIncrementalized(task) then
13: incTask ← GetIncremental(task)
14: δ+ ← incTask(δ+)
15: δ− ← incTask(δ−)
16: else
17: impTask ← GetImpactFunction(task)
18: y ← GetOutput(task)
19: if impTask(δ+, δ−, y) = true then
20: Push(G, task)
21: tmp d ← GetInput(task)
22: ExecuteWorkflow(G, tmp d)
23: return
24: else
25: Push(G, task)
26: break
27: end if
28: end if
29: end while
30: . . .
8.3. Scoping effectiveness
Regarding the effectiveness of this algorithm, note that
the extended version of our algorithm can reduce the
amount of work by making the following assumptions.
First, the use of difference sets to calculate task output
(lines 10–11 and 14–15) is much faster than when using
the complete input data. Second, the output of these re-
executions is likely to return an empty response, and so the
inner while loop can terminate early with G 6= ∅. Third,
the number of non-distributive and non-incrementalized
tasks is small or, alternatively, the provided impact func-
tions are fast, accurate and more effective than the default
‘return true’ implementation.
Noting that all these assumptions are valid for SVI, we
tested the hypothesis that the approach is indeed benefi-
cial. We show in Tab. 5 that running the process using the
proposed algorithm and the SVI-specific diff function we
were able to avoid the majority of re-computations which
used the complete new ClinVar version. We reduced the
number of complete re-executions of the workflow from 495
down to 71. In Tab. A.8 in the appendix we show also the
re-computation matrix for the algorithm which used the
generic diff function. In that case the reduction was less
significant and required 302 complete re-executions. That
is because the generic diff searched for changes in every
single column of the ClinVar data, most of which were
irrelevant to SVI.
Figures 9 and 10 show the effect of running our algo-
17
Table 5: Changes observed in the output of the SVI tool when executed with the difference sets computed for NCBI ClinVar reference database
using the SVI specific δ function;  denotes the need for re-execution with the complete new version of ClinVar (Dac 6= ∅ or Dr 6= ∅),
‘ ’ denotes only task re-execution with the difference sets (Dac = ∅ and Dr = ∅).
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rithm on the re-computation time. The former presents
the average time required to re-compute a single patient
variant file. For the majority of cases running SVI with the
difference sets was much quicker than with complete Clin-
Var data. In a few cases, e.g. when using the difference
between the versions from September and October 2016,
some re-executions were slightly slower than the partial
re-computation. That was due to extensive changes in the
ClinVar database at the time and so almost all rows were
reported as changed. This did not occur, however, when
using the SVI-specific diff function. Then, the total time
was significantly lower than the partial re-computation in
all cases as there were not many changes in the columns
relevant to SVI.
Figure 10 shows the total re-computation time for the
whole patient cohort including the time required to re-
execute tasks with the difference sets and to run the partial
re-computation with the complete new data when the im-
pact function produced true. This figure emphasises the
penalty for running the algorithm when the difference sets
were large compared to actual new data. It also highlights
the importance of the diff and impact functions. Clearly,
the more accurate the functions are the higher runtime
savings may be, which stems from two facts. Firstly, more
accurate diff function tends to produce smaller difference
sets which reduces time of task re-execution (cf. CV se-
lective δ-gen and δ-SVI lines in Fig. 9). Secondly, more
accurate impact function tends to produce false more
frequently, and so the algorithm can more often avoid re-
computation with the complete new version of the data
(cf. the number of black squares vs the total number of
patients affected by a change in Tab. 5).
9. A blueprint for a generic and automated re-
computation framework – challenges
So far we have presented techniques that can be applied
to reduce the cost of recurring re-computation, with refer-
ence to a single case study and without concern for the rel-
ative cost and benefits associated with the re-computation.
Our long term goal is to generalise the approach into a
reusable framework, which we call ReComp, that is able
not only to carry out re-computations by automating a
combination of the techniques we just illustrated, but also
to help decision makers carry out a cost/benefit analysis
to determine when selective re-computation is beneficial.
For this, ReComp must support a number of capabilities,
above and beyond those just illustrated in Fig. 4. With
reference to our execution model:
〈yt′ , ct′〉 = exec(P, xt′ , Dt′) (16)
these are:
1. Detect and quantify changes in input and reference
data, i.e. by accepting data-specific diff X() and
diff D() functions;
2. Estimate the impact of those changes on each mem-
ber yt ∈ Y in a population Y of prior outcomes, i.e.
learn estimates of diff Y (y
t, yt
′
) without having to
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Figure 10: Total time of the SVI workflow for a cohort of 33 pa-
tients depending on the approach taken to re-computation.
compute yt
′
, as well as estimates of the correspond-
ing re-computation cost ct
′
;
3. Use the estimates to prioritise prior outcomes for re-
computation, subject to a limited budget, and
4. Perform the re-computation of the corresponding in-
stances of P , entirely or partially, as we have seen in
this paper.
Note that, at this stage, we do not consider changes in
P itself or any of its software dependencies (as opposed to
the data dependencies). For simplicity we focus on changes
in the data only and do not consider changes in the un-
derlying processes. These are also relevant but require a
separate formalisation, beyond the scope of this paper.
In practice, ReComp is configured as a meta-process that
is able to (i) monitor instances of an underlying process
P and record its provenance as well as details of its cost,
(ii) detect and quantify changes in the data used by P , and
(iii) control the re-execution of instances of P , on demand.
These capabilities are summarised in the loop depicted in
Fig. 11.
Central to ReComp is the idea that decisions about fu-
ture re-executions are informed by analytics on the history
of past executions. To make this possible, each execution
of the form (16) (including re-executions) is controlled by
ReComp, and generates metadata records that include:
• outcomes that are subject to revision;
Updated 
outcomes
Compute/
quantify 
changes
Input  and 
reference 
data Monitor 
changes
Optimise/
prioritise 
outcomes
Estimate 
the impact 
of changes 
and cost of 
refresh
Monitor
cost, collect 
provenance & 
knowledge
History DB
Re-
compute 
selected 
outcomes
Figure 11: The main loop in the ReComp framework that handles
selective re-computation of the user process; thin black arrows denote
the flow of control, thick arrows represent the flow of data.
• provenance of the outcome, either coarse-grained
or fine-grained, depending on the underlying prove-
nance recording facilities associated with the process
runtime;
• execution cost, typically expressed as running time
and data storage volume, again as detailed as al-
lowed by the underlying system. For instance, our
own WFMS, e-SC, provides block-level time record-
ing and per-data-item storage, while other systems
may only provide cumulative times.
Our long-term research hypothesis is that metadata
analytics performed on such history database may yield
viable models to estimate change impact and thus be able
to prioritise re-computations vis-a`-vis a limited budget. In
the rest of this section we discuss a number of challenges
that underpin the implementation of the ReComp frame-
work.
9.1. Monitoring data changes
Managing multiple versions of large datasets is chal-
lenging. Firstly, observing changes in data usually requires
source-specific solutions, as each resource is likely to ex-
pose a different version release mechanism — a version
number being the simplest case. Secondly, the volume of
data to be stored, multiplied by all the versions that might
be needed for future re-computation, leads to prohibitively
large storage requirements. Providers’ limitations in the
versions they make available also translate into a challenge
for ReComp, with some providers not offering access to dif-
ferent versions of their data at all.
A further issue is whether multiple changes to differ-
ent data sources should be considered together or sepa-
rately: in some cases it may be beneficial to group multiple
changes to one resource instead of reacting immediately.
For example, GeneMap updates are published daily, often
with only a few rows changed. Thus, taking into account
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the cost of running the ReComp loop, it may be more ef-
fective to delay the loop and collect a number of updates,
e.g. over a week.
9.2. Calculating and quantifying changes
Suppose two processes managed by ReComp retrieve
different attributes from the same relational database D.
Clearly, for each of these processes only changes to the rel-
evant attributes matter. Thus, the diff () functions, such
as those defined in Sec. 5, are not only type-specific but
also query-specific. For n processes and m resources, this
may potentially require n ·m specialised diff () functions.
Whether we can find more effective ways to compute and
measure data changes is an open question. Additionally,
some input data may be unstructured or semi-structured
and thus calculating the difference between two versions
that is useful in the estimation of their impact may be
challenging in itself.
9.3. Estimation impact and cost of refresh
We define the re-computation problem as finding the
optimal selection of past invocation that can maximise the
benefit of re-computation given changes in the input data
and a budget constraint. Addressing this problem requires
that we first learn impact estimators that can take into
account the history of past executions, their cost and the
changes in the input data, and can feed into the optimisa-
tion problem. This is a hard problem, however, which in
particular involves estimating the difference between two
outputs of process P given changes to some of its inputs.
Clearly, some knowledge of the function that P implements
is required, but that is also process-specific and so difficult
to generalise into a reusable re-computation framework.
Recalling our example with SVI and ClinVar, we would
like to predict whether or not a new variant added to
the database will change patient diagnosis. The technique
showed earlier allowed us to do so to some extent, as we
were able to reduce the number of affected invocations
from 495 to 71, yet more work is needed to find more ac-
curate and more generic techniques.
The problem of learning cost estimators has been ad-
dressed in the recent past, but mainly for specific scenarios
that are relevant to data analytics, namely workflow-based
programming on clouds and grid [43, 44]. But for instance
[45] showed that runtime, especially in the case of machine
learning algorithms, may depend on features that are spe-
cific to the input, and thus not easy to learn. That leaves
the impact and cost estimation as an open challenge.
9.4. Optimising the selection of past executions
Given a limited re-computation budget, and a mea-
sure of benefit of outcome refresh, we can address the fur-
ther problem to select the past executions that are ex-
pected to maximise the benefit given the budget. Using
the impact and cost estimators, we can formulate it as
the 0-1 knapsack problem in which we want to find vector
a = [a1 . . . an] ∈ {0, 1}n that achieves:
max
n∑
i=1
viai subject to
n∑
i=1
wiai ≤ C (17)
where n is the number of past executions, vi is the esti-
mated change impact for execution i, and wi is the es-
timated cost of its re-execution. Importantly, each data
change event triggers an instance of (17) to be solved but
due to expected high cost of re-computation it may be
worth grouping a number of change events together. That
adds complexity to the optimisation problem.
9.5. Black box processes
Running the SVI example in the previous sections, we
assumed that we have insight into the structure and se-
mantics of process P managed by ReComp. That enabled
us to effectively apply techniques for partial process re-
execution. When P is a black box process, however, this
is not possible and other techniques such as incremental
computation [27, 31, 18] may be required. Regardless of
the transparency of P , a common challenge is that for Big
Data analytics intermediate data produced by the process
(or memoised during incremental computation) often out-
grow the actual inputs by orders of magnitude, and thus
the cost of persisting all intermediate results may be pro-
hibitive. An open problem, with some contribution from
Woodman et al. [17], is to find techniques that could bal-
ance the choice of intermediate data to retain in view of a
potential future re-computation, with its cost.
A separate challenge is that the actual re-execution of
process P used in the past may not be straightforward.
It may require redeploying P on a new infrastructure and
ensuring that the system and software dependencies are
maintained correctly, or that the results obtained using
new versions of third party libraries remain valid. Ad-
dressing these architectural and reproducibility issues is a
research area of growing interest [23, 21, 22, 46].
9.6. History database
As mentioned, ReComp needs to collect and store both
provenance and cost metadata. Recording cost requires
the definition of a new format which, to the best of our
knowledge, does not currently exist. Provenance, on the
other hand, has been recorded using a number of formats,
which are system-specific. Even when the PROV prove-
nance model [19] is adopted, it can be used in different
ways despite being designed to encourage interoperabil-
ity. Our recent study [47] shows that the ProvONE,12 an
extension to PROV, is a step forward to collect interop-
erable provenance traces, but is still limited as it assumes
that the traced processes are similar and implemented as
a workflow.
12https://purl.dataone.org/provone-v1-dev
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10. Conclusions and future work
Knowledge decay over time is an important issue that
affects the value proposition of Big Data analytics. It is
especially important for the next generation sequencing
pipelines, in which algorithms and reference data continu-
ously improve. As these pipelines require processing that
can easily exceed hundreds of CPU-hours per patient co-
hort and as they become used on a wider scale,13 relevant
techniques to address knowledge decay and refresh pipeline
results are required.
In this paper we presented our investigation into how
selective re-computation can help address the knowledge
decay issue. Using a case study in the area of clinical
interpretation of genetic variants in humans, with a cohort
of patients from the Institute of Genetic Medicine (IGM)
at Newcastle University, we described three approaches to
selective re-computation: at the process level (partial re-
execution), data level (differential execution), and whole-
cohort level (identification of scope of change).
Regarding partial re-execution, a special role is played
by provenance, which we used to build the minimal pro-
cess subgraph that requires re-execution. For differential
execution, we used diff () functions to calculate difference
sets between two versions of the input data and then, us-
ing these sets, to reduce the amount of processing needed.
Finally, at the whole-cohort level we showed a significant
reduction in the number of patient samples that required
refresh. Overall, we were able to lower the cost of re-
computation to about 10% of the total time needed for
update the previous results. In the immediate future, our
plan is to extend the study to a much larger cohort of
over 1,500 patients [3], which will provide better figures
on actual savings closer to real population scale.
Worth noting is that in this paper we discussed only the
lossless approach to re-computation. Lossless re-computa-
tion is conservative in that any outcome on which the im-
pact cannot be proved to be zero, regardless of how small,
will be refreshed. In contrast, lossy re-computation also
seeks to reduce the amount of work performed on pre-
viously computed outcome. However, lossy re-computa-
tion would try to quantitatively estimate the extent of
the impact, and use the estimates to decide whether and
when to refresh the outcomes. We view this as a more
general re-computation decision problem which involves a
cost/benefit analysis.
This study on variant interpretation informs the more
ambitious ReComp project.14 Our immediate next step is to
apply the techniques presented in this paper to other parts
of the variant calling pipeline. We are now developing a
generic meta-process that can observe changes and con-
trol re-computation for a variety of underlying, resource-
intensive analytics processes, as well as support business-
level re-computation decisions vis-a`-vis a resource budget.
13https://www.genomicsengland.co.uk/
the-100000-genomes-project/
14http://recomp.org.uk
In Sec. 9 we outlined a number of the research and tech-
nical challenges associated with this vision.
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Appendix A. Input data
Table A.6: Basic properties of a set of patient variant files used in
the experiments.
Phenotype
hypothesis Variant file
Record
count
File size
[MB]
Alzheimer’s
disease
B 0198 23,803 38.5
B 0201 24,809 39.9
B 0202 24,442 39.4
B 0203 24,654 39.8
B 0208 24,264 39.1
B 0209 24,166 39.1
B 0214 23,370 37.9
B 0229 24,133 39.0
B 0331 23,897 38.8
B 0338 24,243 39.2
B 0358 24,181 39.1
B 0365 24,070 38.9
B 0370 23,798 38.4
B 0384 24,905 40.2
B 0396 23,886 38.8
C 0065 23,469 38.0
C 0068 24,098 39.0
C 0071 23,741 38.4
C 0072 22,946 37.3
C 1457 23,649 38.3
CADASIL D 1136 24,511 39.6
Frontotemporal
dementia –
Amyotrophic
lateral sclerosis
B 0307 24,052 39.0
C 0051 23,921 38.7
C 0053 23,980 38.8
C 0056 23,805 38.6
C 0098 22,948 37.4
C 0171 24,387 39.6
D 0830 24,132 39.1
D 0854 24,133 39.0
D 0899 24,034 38.8
D 1041 24,463 39.5
D 1049 24,473 39.5
D 1071 24,102 39.0
Table A.7: Basic properties of the OMIM GeneMap and ClinVar
reference databases used in the experiments.
Database Version Record count
File size
[MB]
OMIM GeneMap 16-04-28 15,871 2.65
16-06-01 15,897 2.66
16-06-02 15,897 2.66
16-06-07 15,910 2.66
16-10-30 16,031 2.69
16-10-31 16,031 2.69
16-11-01 16,031 2.69
16-11-02 16,031 2.69
16-11-30 16,063 2.70
NCBI ClinVar 15-07 304,207 95.0
15-08 252,656 81.6
15-09 259,714 87.1
15-10 262,498 88.1
15-11 277,902 93.5
15-12 279,174 94.5
16-01 280,379 94.8
16-02 285,041 96.6
16-03 286,684 94.7
16-04 290,432 96.1
16-05 290,815 96.1
16-06 306,503 101.4
16-07 320,469 106.7
16-08 326,856 109.2
16-09 327,632 109.5
16-10 349,074 121.3
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Table A.8: Changes observed in the output of the SVI tool when executed with the difference sets computed for NCBI ClinVar reference
database using the generic δ function;  denotes the need for re-execution with the complete new version of ClinVar (Dac 6= ∅ or Dr 6= ∅),
‘ ’ denotes only task re-execution with the difference sets (Dac = ∅ and Dr = ∅).
B
_0198
n
n
n
n
n
n

n
n


n
n
n
n
B
_0201
n
n
n
n
n
n

n
n
n

n
n

n
B
_0202
n
n

n
n


n
n


n


n
B
_0203
n
n

n
n
n

n
n


n
n
n
n
B
_0208
n
n
n
n
n
n

n
n


n
n

n
B
_0209
n
n
n
n
n
n

n
n



n
n
n
B
_0214
n
n

n
n
n

n
n


n
n
n
n
B
_0229
n
n
n
n
n
n

n
n


n
n
n
n
B
_0331
n
n
n
n
n
n

n
n



n
n
n
B
_0338
n
n

n
n
n

n
n


n
n
n
n
B
_0358
n
n

n
n
n

n
n



n
n
n
B
_0365
n
n
n
n
n
n

n
n



n
n
n
B
_0370
n
n

n
n
n

n
n


n
n
n
n
B
_0384
n
n

n
n


n
n


n


n
B
_0396
n
n

n
n
n

n
n



n
n
n
C
_0065
n
n
n
n
n
n

n
n



n
n
n
C
_0068
n
n

n
n
n

n
n



n
n
n
C
_0071
n
n

n
n


n
n



n

n
C
_0072
n
n

n
n
n

n
n


n
n
n
n
C
_1457
n
n
n
n
n
n

n
n



n

n
C
A
D
A
S
IL
D
_1136
n
n
n
n
n


n






n
B
_0307
n
n

n
n


n




n

n
C
_0051
n
n

n
n

n
n


n
n


n
C
_0053
n
n

n
n


n






n
C
_0056
n
n

n
n

n
n



n


n
C
_0098
n
n

n
n


n


n



n
C
_0171
n
n

n
n


n


n



n
D
_0830
n
n

n
n


n






n
D
_0854
n
n

n
n

n
n


n
n


n
D
_0899
n
n

n
n


n






n
D
_1041
n
n

n
n

n
n


n
n


n
D
_1049
n
n

n
n









n
D
_1071
n
n

n
n


n






n
Phenotype 
hypothesis
08/15
09/15
10/15
11/15
12/15
01/16
02/16
03/16
04/16
05/16
06/16
07/16
08/16
09/16
10/16
Alzheimer's disease
Frontotemporal Dementia-
Amyotrophic Lateral Sclerosis
Variant 
file
ClinVar 
version
25
